Teachable Moments: Scurvy and Serum Ammonia—Clinical Context, Cost, and Diagnostic Reasoning

Teachable Moment: Scurvy

• Case overview:

  • Middle-aged woman presented to the emergency department with severe ankle pain, generalized body aches, malaise, and a petechial rash over the extremities. Symptoms had existed for about a year; on presentation her husband brought her in due to worsening rash and crippling ankle pain.
  • Prior workup included outpatient evaluation with laboratory tests, whole-body CT with IV contrast, and whole-body scintigraphy; all tests were normal.
  • Treated with pain medications and antidepressants prior to presentation.
  • On exam: diffuse, nonblanching petechial rash on frail skin of arms/legs; faint ecchymoses around ankles; tender ankles with limited ROM; joint radiographs normal. Hemarthrosis suspected but no trauma history; coagulation parameters normal.
  • Other symptoms: persistent dryness of eyes and mouth for the past year.
  • Additional history: dietary avoidance of fruits and vegetables for several years; gum bleeding with eating/ brushing; poor dentition; gingival erythema.
  • Key diagnostic clue: perifollicular distribution of petechiae and corkscrew hairs; these oral/dental signs and hair pattern pointed toward scurvy rather than Sjögren vasculitis.
  • Final diagnosis confirmed by laboratory result: undetectable serum vitamin C level; treatment with orange juice and vitamin C led to dramatic improvement within 2 weeks (rash receded; able to walk again).
  • After improvement, lab confirmation of vitamin C deficiency was obtained.

• Diagnostic clues and clinical reasoning:

  • Scurvy is a dietary deficiency of vitamin C; classic features arise from impaired collagen synthesis (e.g., bruising, bleeding gums, petechiae, corkscrew hairs, arthralgias, Sjögren-like symptoms, depression) and may include fatigue and malaise.
  • The perifollicular petechiae pattern and corkscrew hairs were key clinical clues distinguishing scurvy from vasculitis or Sjögren-like syndromes.
  • Diet history was critical: prolonged avoidance of fruits/vegetables and gingival bleeding pointed to nutritional deficiency rather than autoimmune disease.

• Management and outcomes:

  • Initiated therapy with vitamin C supplementation and dietary correction (orange juice and vitamin C).
  • Within 2 weeks: rash diminished and pain/ambulation improved.
  • Laboratory confirmation: serum vitamin C undetectable.

• Broader implications: what this teachable moment illustrates about clinical practice

  • Scurvy is rare in 21st-century United States; nevertheless, delays and extensive testing can occur before the correct diagnosis is reached.
  • Cost and patient burden: the patient was billed more than $\$40{,}000$ for medical workup over the preceding year, in addition to emotional distress.
  • The diagnostic power of the history and physical examination: several studies quantify how diagnoses are determined by history and physical exam relative to investigations.
  • In outpatient settings, final diagnosis was determined by history ($56\%$), physical examination ($17\%$), and investigations ($23\%$) [1].
  • In hospitalized patients, a physical examination finding altered diagnosis and management in $26\%$ of cases; in $7\%$ of patients, physical exam findings were validated by a consulting specialist and not discoverable by imaging [3].
  • In another inpatient study, $20\%$ of all diagnoses came from the history alone, with an additional $40\%$ from history plus physical examination; imaging was useful in only about $6\%$ of cases [4].
  • Overreliance on high-tech diagnostics can yield diminishing returns; imaging use has expanded, yet better outcomes have not consistently followed.
  • Imaging use has doubled from 2000 to 2006 based on Medicaid data, reflecting a broader trend toward high-tech testing [1].
  • Policy implications: Congress and insurers have proposed regulatory measures to curb unnecessary imaging in response to cost and resource use concerns [1].
  • Takeaway: In value-based medicine, the history and physical exam remain among the most powerful diagnostic tools, and cost-effective care emphasizes avoiding unnecessary testing when history and exam strongly suggest a diagnosis.

• Key concepts and terms (with values and references):

  • Scurvy = dietary deficiency of vitamin C; clinical features include $\text{bruising},\quad \text{bleeding gums},\quad \text{petechial rash},\quad \text{hemarthrosis},\quad \text{corkscrew hairs},\quad \text{arthralgias},\quad \text{weakness},\quad \text{malaise},\quad \text{depression}$.
  • Diagnostic confirmation: \text{serum vitamin C} < \,\text{undetectable}; respond to vitamin C supplementation.
  • Cost and resource use: outpatient vs inpatient diagnostic yield; total cost of workup can be substantial (example $\$40{,}000$).
  • Imaging trends: imaging use doubled 2000–2006; not clearly associated with improved outcomes [1].
  • References for context: [1] Iglehart, 2009; [2] Sandler, 1980; [3] Reilly, 2003; [4] Paley et al., 2011.

• Ethical/practical implications:

  • Balancing technology with bedside medicine to avoid patient harm and unnecessary costs.
  • Ensuring dietary history and physical signs are thoroughly assessed before pursuing expensive diagnostics.
  • Patient experience and emotional burden from prolonged diagnostic uncertainty.

• Additional notes for exam preparation:

  • Remember perifollicular hemorrhages and corkscrew hairs as key dermatologic clues for nutritional vitamin C deficiency.
  • Always correlate dietary history with physical signs before attributing symptoms to autoimmune or systemic diseases.

Teachable Moment: The Importance of Clinical Context When Interpreting Serum Ammonia Levels

• Case overview:

  • Aman, in his early 40s, presented to his primary care physician with intermittent anxiety attacks and progressive fatigue.
  • He is an active-duty service member with a history of panic disorder since deployment to Iraq 6 years prior.
  • Symptoms worsened after relocation to a remote post in Eastern Asia; anxiety management with lorazepam was insufficient; venlafaxine had to be stopped due to light-headedness.
  • Initial workup included serum ammonia and cortisol testing and a mononucleosis screen; due to limited resources, the ammonia sample was frozen in an EDTA tube and sent to a lab in California for processing, taking more than a week to return.
  • Ammonia result: $643\ \mu g/dL$ (reference $27-102\ \mu g/dL$; to convert to $\mu mol/L$, multiply by $0.714$)]; hepatic panel showed mildly elevated ALT and GGT; RUQ US showed limited hepatic steatosis.
  • Due to lack of clear hepatic cause for hyperammonemia, the patient was transferred to a tertiary center in the United States for further evaluation.
  • Under a medical geneticist’s direction, extensive laboratory workup (urine amino acids, urine organic acids, plasma amino acids) was performed before and after a large protein load; all results were normal; subsequent ammonia levels returned to normal, suggesting the initial elevation was false.
  • The patient returned to overseas duty after approximately 30 days in the United States.

• Diagnostic reasoning and clinical interpretation:

  • Teachable point: Chronic mild fatigue in primary care is challenging; screening for common causes is reasonable, but broad, untargeted testing can be impractical and potentially harmful due to false positives and patient burden.
  • In this case, there were no clear indications for serum ammonia testing: no history of alcohol abuse or hepatitis risk factors; no evidence of cirrhosis on examination; probability of end-stage liver disease was exceedingly low.
  • Partial urea cycle disorders (defects in nitrogen metabolism) can present with nonspecific psychiatric symptoms but are not common; there were no other clinical features suggesting a urea cycle disorder (e.g., nausea/vomiting, neurologic symptoms, or family history of metabolic disease) [1].
  • The ammonia test is particularly delicate: results can be spuriously elevated; blood samples must be analyzed promptly because levels rise in standing blood due to in vitro deamination of amino acids; freezing samples for later analysis is common but accuracy is uncertain [2].
  • Other metabolic abnormalities can contribute to unreliable ammonia results; thus, a positive ammonia test without supportive clinical context may be misleading.

• Clinical and systemic implications:

  • Avoiding unnecessary ammonia testing in low-yield situations reduces patient anxiety, reduces healthcare waste, and avoids cascading follow-up testing.
  • If ammonia testing is pursued, ensure the pre-analytical conditions are optimal: rapid processing, appropriate anticoagulant, minimal delay, and awareness that sample handling can affect results.
  • Recognize that Partial Urea Cycle Disorders may be triggered by stress or emotional events but require a compatible clinical picture and targeted metabolic testing; in this case, insufficient indicators were present.

• Key data points (for quick recall):

  • Initial ammonia: $643\ \mu g/dL$; reference range $27-102\ \mu g/dL$; conversion to $\mu mol/L$: $643\times 0.714\approx 459\ \mu mol/L$.
  • ALT: $89\ \text{U/L}$; GGT: $81\ \text{U/L}$; RUQ ultrasound: limited hepatic steatosis.
  • Subsequent evaluations: all urinal/serum amino acids and related tests normal; ammonia levels later within normal limits.
  • The patient’s fatigue symptoms were temporally linked to deployment-related stressors, not a chronic hepatic/urea-cycle pathology.
  • Practical caution: ammonia testing is a sensitive, delicate test with a high potential for false positives if pre-analytical conditions are not optimal [2].

• Takeaway messages for practice:

  • In patients with fatigue and anxiety without clear hepatic risk factors, ammonia testing should be used judiciously and only when clinically indicated.
  • If ammonia testing is performed, ensure rapid sample processing and minimize delays; do not rely on delayed results from frozen samples when possible.
  • Use a thorough history and physical exam to drive test selection; avoid broad panels that can yield false positives and unnecessary interventions.

• Ethical/practical implications:

  • The case highlights potential harms from unnecessary testing, including patient anxiety, unnecessary specialization referrals, and resource use in a setting with limited access to rapid laboratory processing.
  • It reinforces the principle of “primum non nocere” (first do no harm) in diagnostic testing by emphasizing test appropriateness and pre-test probability.

• Connections to broader themes:

  • Diagnostic stewardship: aligning test choice with clinical probability to reduce false positives and unnecessary costs.
  • The importance of context in interpretation of laboratory data: laboratory values must be interpreted within clinical presentation, pre-test probability, and test reliability.

• References and context notes:

  • The discussion cites general literature on test utilization and the value of history/physical examination in diagnosis [1]-[4].
  • Specific figures include: ammonia reference values, conversion factors, and cautions about pre-analytical handling [2].

• Summary takeaways (for exam-ready recall):

  • Scenarios where history and physical exam drive diagnosis can prevent costly, invasive, or unnecessary tests; scurvy is a classic example where clinical signs (perifollicular petechiae, corkscrew hairs, gingival changes) and dietary history rapidly point to vitamin C deficiency and respond to simple therapy.
  • Ammonia testing can yield false positives if pre-analytical factors are not tightly controlled; always interpret ammonia results in clinical context and consider test appropriateness before ordering.